Target intelligence / Profile preview

Host intestinal epithelium and gut ecosystem

Molecular classification
Other
01

Overview

The host intestinal epithelium and gut ecosystem constitute a dynamic biological interface essential for nutrient absorption, metabolic regulation, and immune homeostasis [1]. The intestinal epithelium acts as a selective semi-permeable barrier, while the gut ecosystem, or microbiota, consists of a diverse community of bacteria, fungi, and viruses that interact with host cells [2]. This system is responsible for the primary defense against ingested pathogens and the maturation of the mucosal immune system [3]. Dysregulation of this system, often termed dysbiosis or barrier dysfunction, is a hallmark of various pathologies, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic syndromes like obesity [4]. Pharmacological interventions often target specific components within this niche, such as the mucosal barrier or microbial metabolites, to restore balance and prevent systemic inflammation [5]. Because it encompasses a vast array of cell types and species, it is characterized as a complex therapeutic environment rather than a discrete molecular target [6]. [1] https://www.nature.com/articles/nrgastro.2014.150 [2] https://pubmed.ncbi.nlm.nih.gov/24997038/ [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337124/ [4] https://pmj.bmj.com/content/88/1037/145 [5] https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-016-0303-2 [6] https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-014-0189-7

Other names
Gut microbiome-host interfaceIntestinal mucosal barrierGut-microbiota axisIntestinal ecosystemGastrointestinal niche
02

Mechanism of action

Modulation of microbial composition, restoration of epithelial barrier integrity, suppression of mucosal inflammation, and competitive inhibition of pathogens.

03

Biological functions

Nutrient absorptionBarrier functionImmune responseMetabolic homeostasisPathogen defenseVitamin synthesis
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeObesityColorectal cancerCeliac diseaseInfectionMetabolic syndrome
05

Safety considerations

DysbiosisBacterial translocationSystemic infectionVariable patient responseImmunogenicityAntibiotic resistance
06

Interacting drugs

Rifaximin

6 more in the full profile.

07

Biomarkers

Fecal calprotectinZonulinShort-chain fatty acids (SCFAs)Microbial alpha diversityC-reactive protein

Beyond the preview

Go deeper on Host intestinal epithelium and gut ecosystem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelium and gut ecosystem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call